Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LeoPARDS: Levosimendan for Prevention of Acute Organ Dysfunction in Sepsis
2012-005159-18Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levosimendan in septic shock, multiple organ dysfunction syndrome (MODS), sponsored by Imperial College London. Started Aug 2013; status: completed.
02
Drugs
levosimendan
03
Conditions
septic shockmultiple organ dysfunction syndrome (MODS)
Beyond the preview
Go deeper on 2012-005159-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005159-18.